clinical research capabilities bioavailability
play

Clinical Research Capabilities Bioavailability & Bioequivalence - PowerPoint PPT Presentation

Clinical Research Capabilities Bioavailability & Bioequivalence Studies Clinical Research Division CLINICAL RESEARCH SERVICES 03 VIMTA STRENGTHS Experience 32 years of track record in supporting Pharma & Life Sciences


  1. Clinical Research Capabilities Bioavailability & Bioequivalence Studies Clinical Research Division

  2. CLINICAL RESEARCH SERVICES 03

  3. VIMTA STRENGTHS • Experience – 32 years of track record in supporting Pharma & Life Sciences industries Pharma & Life Sciences industries • A Truly Independent CRO – Not affiliated to any Pharma or Life Sciences organization • Core Value – Integrity of service through honesty, responsibility and uncompromising devotion to Quality • Strong Regulatory Compliance – Long standing experience in working as per different regulatory frameworks • One-stop-shop for testing your generic pipeline One-stop-shop for testing your generic pipeline • 900 + knowledgeable, experienced, motivated and committed team • Effective and Efficient Project Management 04

  4. Bioavailability & Bioequivalence Studies 05

  5. REGULATORY AUDIT EXPERIENCE REGULATOR NO. OF INSPECTIONS DCGI (India) DCGI (India) 4 4 FDA (USA) 10 MHRA (UK) 2 BfArM (Germany) 2 ASNM (France) 2 WHO 4 DRAs of Denmark, Portugal & DRAs of Denmark, Portugal & 1 1 Sweden* MCC (South Africa) 2 ANVISA (Brazil) 2 NPCB (Malaysia) 1 06

  6. BA/BE SERVICES • Full service for BA/BE studies (1) In healthy volunteers & (2) In patients (2) In patients – Study designing & protocol development – Method development & validation – Pre-study approvals for project initiation – Project execution as per protocol and standard procedures – Pre & post project regulatory support – Statistical data analysis Statistical data analysis – eCTD submission • Standalone services (Clinic/Bioanalytical/clinical Lab) 07

  7. EXPERIENCE • Study designing & protocol preparation – Cross over, parallel, steady state, average Cross over, parallel, steady state, average bioequivalence (full/reference replicate designs) • Testing of various dosage forms – Tablets, capsules, orally disintegrating strips, gels, oral solutions, dermal patches and injectables solutions, dermal patches and injectables • Execution of studies with large sample size • Over 350 validated bio-analytical methods 08

  8. EXPERIENCE • > 1700 BA/BE studies for customers across the globe • Successfully contributed to more than 120 ANDAs and 505.B(2) applications in regulated markets and 505.B(2) applications in regulated markets • Submissions to regulatory agencies: Regulatory Agency Studies No. of pivotal studies conducted since conducted so far DCGI (India) 1994 >400 USFDA USFDA 2000 2000 >300 >300 EU 2001 >50 WHO 2000 >15 Others (Health Canada, 2000 >50 TGA, MCC, etc.) 09

  9. IT POWERED PROCESSES • Biometric solutions for identification of volunteers and cross Biometric solutions for identification of volunteers and cross participation status • Audio-Video recording of consent process • MedDRA for Adverse Event Coding • Analyst software version 1.4.2 for LCMS MS • Mass Lynx version 4.1 for Micro Mass • SAS version 9.2 Enterprise Guide 4.2 • SAS version 9.2 Enterprise Guide 4.2 • WinNonLin version 6.2 for PK analyses • Electronic Document Management System • SAP for Material Management 10

  10. CLINIC • 180 beds clinic capacity • 180 beds clinic capacity • 29000 Healthy Volunteers Database • In house volunteer screening facility • In house clinical lab for safety assessments • Fully equipped ICU to handle medical emergencies • Synchronized clock systems (RF mesh network) • Pharmacy for controlled storage of Investigational Products Pharmacy for controlled storage of Investigational Products • High volume centrifuges (temperature controlled)& freezers • In-house catering facility to provide standardized food 11

  11. CLINICAL LAB • Dedicated automated biochemistry analyzers Dedicated automated biochemistry analyzers • Back-up equipments to ensure continuity • Testing for drugs of abuse Accreditations • ISO/IEC 15189 by NABL (National Accreditation Board for Testing & Calibration Laboratories, India) Calibration Laboratories, India) • College of American Pathologists (CAP) 12

  12. BIOANALYTICAL • Pool of 24 Mass spectrometers for rapid turnaround • Different varients of LC MS MS (API 2000/3200/4000 & Micromass) • LC MS MS 8050/8060 (for molecules with low sensitivity) • GC MS MS (single & triple quadrapole) • ICP MS for elemental analysis • ELISA analyses for Iron preparations • Dedicated equipment & scientists for each project • Dedicated QC team for data verification • Power backup for all equipments 13

  13. SAMPLE STORAGE FACILITIES • Cold storage, across 2 Sites in Hyderabad : Cold storage, across 2 Sites in Hyderabad : • Eleven Deep Freezers – four (-) 20 0 C – seven (-) 70 0 C – (-) 20 0 C walk-in-chamber • Long term data archival facility • Dedicated storage facilities for clinical samples, bioanalytical samples, and clinical lab kits with central monitoring facility 14

  14. Thank You For Your Time Vimta - CR Division www.vimta.com 15

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend